1.
Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation. Univ. Heart J. [Internet]. 2020 Oct. 11 [cited 2026 Jul. 1];16(2):99-105. Available from: https://www.banglajol.info/index.php/UHJ/article/view/49666